SEC Form 4 · accession 0001597014-15-000004
NephroGenex, Inc. · NRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bob Peterson
Officer — VP of Prod. Dev. & Reg. Aff's.
Period of report
Apr 30, 2015
Accepted (ET)
May 4, 2015 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001338095
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Common StockF1 | $7.31 | Apr 30, 2015 | A | 11,500 | A | Apr 30, 2016 | Apr 30, 2025 | Common Stock | 11,500 | 11,500 | D |
Explanation of responses
- F125% of the shares underlying the options will vest on April 30, 2016 and the remainder of the shares underlying the options will vest on a pro rata monthly basis for a three-year period following April 30, 2016.